IFNA1 and neoplasm: However, some studies have shown that PRRs and IFN signals promote tumor progression or immune tolerance, but not pro-inflammatory effect in immune cells (55), indicating that we need to target the PRRs of immune cells in TME in the future to improve the efficacy.